Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The immunotolerant human leukocyte antigen-G (HLA-G) molecules have a major role in fetal-maternal tolerance during pregnancy. Interaction between these molecules and uterine natural killer (uNK) cells inhibitory receptors prevents NK cell invasion against fetus trophoblast cells. The aim of this study was to evaluate the percentages of uNK cells and HLA-G1 and HLA-G5 isoforms expression in vaginal discharge of threatened-abortion women in comparison with control. In a case-control study, we investigated 30 threatened-abortion women with bleeding or spotting less than 20 weeks of pregnancy as compared to 30 normal pregnant women. uNK cells percentage was assessed by flow cytometry. Furthermore, we evaluated HLA-G1 and HLA-G5 isoforms expression by Real-Time PCR in these groups. The results of this study showed that threatened-abortion women had increased uNK cells and decreased T cells percentage in vaginal discharge in comparison with normal pregnant women (p = 0.01, p = 0.003, resp.). In addition, HLA-G1 isoform had lower expression in threatened-abortion women in comparison with control group (p = 0.0001). The increase of uNK cells level with the decrease of HLA-G expression in vaginal discharge of threatened-abortion pregnant women is an indicator of mother's immune dysregulation. It is concluded that HLA-G expression level with uNK cells percentage can be determined as a diagnostic marker for threatened-abortion women.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609863 | PMC |
| http://dx.doi.org/10.1155/2015/692198 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intimate partner violence and delays in obtaining contraception among young people in California and Texas.
Contraception
September 2025
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, 490 Illinois St, San Francisco, CA 94158; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, 1001 Potrero Ave
Objective: Experiencing intimate partner violence (IPV) can negatively impact young people's reproductive autonomy, including making it more challenging to get contraception. This study examined the association between IPV and delays in obtaining contraception in a sample of young women from California and Texas.
Study Design: The data are from a supplementary study to a cluster randomized controlled trial conducted with young people sexually-active within the past year recruited at 29 community colleges during the COVID-19 pandemic (May 2020-May 2023).
Domestic violence and outcome of pregnancy among pregnant females at Alzahraa University Hospital.
Sci Rep
August 2025
Department of Obstetrics and Gynecology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Violence against women is a distressing issue, particularly when the victim is pregnant. However, the pregnancy outcomes of many pregnant women who were subjected to violence are complicated. The present research aimed to evaluate the prevalence of domestic violence against pregnant women and its consequences on the outcome of pregnancy.
View Article and Find Full Text PDFProgestogen therapy in threatened miscarriage and unexplained recurrent pregnancy loss: Recommendations by the Thai interest group.
J Obstet Gynaecol Res
August 2025
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Aim: Threatened miscarriage and unexplained recurrent pregnancy loss (RPL) pose significant physical and psychological challenges for women and their families globally. The lack of local guidelines and variations in recommendations by existing guidelines result in inconsistent management of these conditions in Thailand. The Thai interest group aims to provide recommendations to healthcare providers for the use of progesterone supplementation in women experiencing threatened miscarriage and unexplained RPL.
View Article and Find Full Text PDFReconsidering RhIg Following Threatened, Spontaneous, or Induced Abortions in the First Trimester.
J Obstet Gynaecol Can
July 2025
Laboratory Medicine Program, University Health Network, Toronto, ON; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON. Electronic address:
Routine Rh(D) immunoglobulin (RhIg) administration following first-trimester threatened, spontaneous, or induced abortions is a long-standing practice, but emerging evidence suggests limited benefit. This editorial reviews the outdated data that have informed current guidelines and presents contemporary literature demonstrating a negligible risk of RhD alloimmunization at early gestational ages. Recent studies challenge the necessity of RhIg in the first trimester and highlight the clinical, resource, and equity-related harms of routine use.
View Article and Find Full Text PDFFirst-trimester bleeding: Can ultrasound and biochemical developmental markers deepen our understanding of threatened miscarriage?
Radiography (Lond)
August 2025
Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Malta. Electronic address:
Introduction: Understanding the gestational behaviour of ultrasound and biochemical markers in early pregnancy is essential for improving clinical prediction. This study applies statistical modelling to explore how these markers evolve across gestation, with a particular focus on comparing their trajectories in women presenting with threatened miscarriage (TM) versus those with asymptomatic pregnancies.
Methods: A prospective case-control study was conducted with 177 participants, divided into a study group (TM group) and a control group.